Corpus coverage

319,975 slides

319,974 are described (100%), so the treemap can explain the corpus instead of just counting files.

Total slides
319,975
Described
319,974
Pending
1

Slide type composition

dynamicclickable
Slide type

Showing 319,974 described slides — 100.0% of 319,975 rendered pages

Tile area is proportional to slide count. Click a category to open its subtype map.

all document kinds · all orientations

Slide collection

216,541-216,570 of 319,975

filter-aware
72
Absci | Investor Presentation Deck | 111 slidesAbsci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
73
Absci | Investor Presentation Deck | 111 slidesAbsci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
74
Includes code snippets as decorative background elements.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
75
Absci | Investor Presentation Deck | 111 slidesAbsci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
76
Absci | Investor Presentation Deck | 111 slidesAbsci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
77
Absci | Investor Presentation Deck | 111 slidesAbsci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
78
The slide uses a process flow framework to show the integration of AI across the drug development lifecycle.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
79
The slide outlines a proprietary workflow combining AI-driven design with experimental validation.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
80
The slide uses a split-screen layout to contrast project objectives with results.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
81
The slide uses a dot plot to show binding affinity vs sequence diversity and a bar chart to compare binding rates.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
82
The slide shows two dose-response curves (Cell Surface Binding and ADCC) and two molecular surface models for epitope mapping.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
83
The slide uses a Gantt-style chart to illustrate the overlap of two batches of targets.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
84
The slide uses a process flow framework to show the progression from target discovery to optimized antibodies.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
85
The slide features a circular flywheel diagram on the left and a breakdown of the wet lab validation process on the right.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
86
The slide uses molecular visualization of RBD mutations and a table showing KD (binding affinity) values, highlighting the poor binding (607 nM) to the beta variant.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
87
The slide uses a two-step process flow (1 and 2) to explain the technical methodology of their AI-driven drug discovery platform.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
88
The slide uses a process flow (1 -> 2) followed by a scatter plot validation and a summary table of Pearson R values.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
89
SPR stands for Surface Plasmon Resonance. The charts show binding affinity (KD) comparisons.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
90
The slide uses a process diagram to show the AI workflow and a table to quantify the binding affinity (nM KD) improvements.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
91
The slide uses a consistent visual metaphor of a Y-shaped antibody binding to three distinct targets in each of the three columns.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
92
The slide uses a 5-column layout with icons to represent different capabilities of the platform.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
93
Includes pseudo-code snippets in the background.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
94
Absci | Investor Presentation Deck | 111 slidesAbsci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
95
Absci | Investor Presentation Deck | 111 slidesAbsci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
96
The chart uses a horizontal bar format to represent development progress. Color coding distinguishes between 'Potential First in Class' (blue) and 'Potential Best in Class' (red).Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
97
Includes a biological pathway diagram (Takedatsu 2008) and market data points.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
98
The scatter plot shows a Pearson R of 0.74 for N=5389 data points.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
99
The chart is a dot plot showing affinity (KD) vs edit distance from parent binder. The benchmark is a horizontal dashed line.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
100
The slide uses a side-by-side comparison structure to detail the value proposition of two specific drug candidates.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit
101
The slide illustrates a dual-pathway process leading to a unified AI-driven optimization step.Absci | Investor Presentation Deck | 111 slides · Absci
Conference presentation Investor relations 1 hit